Back to Search
NINA SHAH, M.D.
M.D.
Internal Medicine Physician
NPI: 1063692614IndividualAccepts Medicare
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Advanced CML: therapeutic options for patients in accelerated and blast phases.
PMID 18397679·J Natl Compr Canc Netw·2008
6-review
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.
PMID 19061839·Cancer Cell·2008
8-other
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
PMID 18541900·J Clin Oncol·2008
3-trial
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.
PMID 17710227·J Clin Invest·2007
7-preclinical
Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
PMID 15380227·Bioorg Med Chem Lett·2004
8-other
The effect of recombinant human erythropoietin on the development of retinopathy of prematurity.
PMID 19565433·Am J Perinatol·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVENUE, 4TH FLOOR, BOX 0324
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-9364
Quick Facts
- NPI
- 1063692614
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile